SKI Market

A+| A| A-|

Indian Indices

Sensex

73,319.55 185.23
( 0.25%)

Global Indices

Nasdaq

46,577.55 215.03
(0.46%)

Dow Jones

6,594.89 45.37
(0.69%)

Hang Seng

52,384.74 -1,354.94
(-2.52%)

Nikkei 225

10,436.29 71.50
(0.69%)

Forex

USD-INR

93.85 -0.46
(-0.49%)

EUR-INR

107.97 -0.33
(-0.30%)

GBP-INR

124.03 -0.65
(-0.52%)

JPY-INR

0.59 0.00
(-0.26%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Aarti Drugs Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

524348

INE767A01016

147.0110661

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AARTIDRUGS

17.07

3169.81

EPS(TTM)

Face Value()

Div & Yield %

20.35

0.29

Back

Unjha Formulations standalone net profit rises 9.09% in the December 2025 quarter

Feb 04,2026

Net profit of Unjha Formulations rose 9.09% to Rs 0.24 crore in the quarter ended December 2025 as against Rs 0.22 crore during the previous quarter ended December 2024. Sales rose 17.29% to Rs 4.41 crore in the quarter ended December 2025 as against Rs 3.76 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	4.41	3.76	17
OPM %	5.67	6.12	-
PBDT	0.28	0.24	17
PBT	0.24	0.22	9
NP	0.24	0.22	9

73,319.55 185.23 ( 0.25%)

46,577.55 215.03 (0.46%)

6,594.89 45.37 (0.69%)

52,384.74 -1,354.94 (-2.52%)

10,436.29 71.50 (0.69%)

93.85 -0.46 (-0.49%)

107.97 -0.33 (-0.30%)

124.03 -0.65 (-0.52%)

0.59 0.00 (-0.26%)